0.7550SEK-5.74%Mkt Cap: 233.43M SEKP/E: —Last update: 2026-05-13
Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatripta…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B-59.31
P/S25.98
EV/EBITDA-16.67
EV/Revenue26.01
EPS (TTM)-0.21
EPS (Forward)0.00
Cash Flow & Leverage
FCF Yield0.69%
FCF Margin17.85%
Operating CF-35.04M SEK
CapEx (TTM)—
Net Debt/EBITDA-0.02
Net Debt275.00K SEK
Technical
SMA 500.8984 (-16.0%)
SMA 2000.7133 (+5.8%)
Beta1.20
S&P 52W Chg24.23%
Avg Vol (30d)945.26K
Avg Vol (10d)1.37M
Technical Indicators
RSI (14)34.3
MACD-0.0409
MACD Signal-0.0210
MACD Hist.-0.0199
BB Upper1.091 SEK
BB Middle0.9061 SEK
BB Lower0.7210 SEK
BB Width40.85%
ATR (14)0.0785 SEK
Vol Ratio (20d)1.05x
52W Range
0.392839% of range1.330
52W High1.330 SEK
52W Low0.3928 SEK
Profitability
Gross Margin100.00%
EBITDA Margin-156.02%
Profit Margin-432.80%
Oper. Margin-50271.43%
ROE1004.05%
ROA-95.39%
Revenue Growth-99.40%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio0.05
Quick Ratio0.05
Book Value/Sh-0.0160 SEK
Cash/Share0.0010 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.245.98M
Float211.46M
Insiders17.40%
Institutions7.38%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap233.43M SEK
Enterprise Value233.71M SEK
Revenue (TTM)8.98M SEK
Gross Profit8.98M SEK
Net Income (TTM)-38.89M SEK
Revenue/Share0.0480 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees4
Last Price0.7550 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0007280326